1. [Results of adjuvant chemotherapy of operated high risk cervix carcinoma]
- Author
-
T, Dimpfl, M, Stumpfe, J, Baltzer, and T, Genz
- Subjects
Adult ,Uterine Cervical Neoplasms ,Adenocarcinoma ,Middle Aged ,Hysterectomy ,Combined Modality Therapy ,Disease-Free Survival ,Carboplatin ,Chemotherapy, Adjuvant ,Lymphatic Metastasis ,Antineoplastic Combined Chemotherapy Protocols ,Carcinoma, Squamous Cell ,Humans ,Female ,Neoplasm Invasiveness ,Fluorouracil ,Aged ,Follow-Up Studies ,Neoplasm Staging - Abstract
Patients with carcinoma of the cervix and histologically proven blood vessel invasion have a poor prognosis. At the I. Frauenklinik der Universität München, 34 women were enrolled for a prospective study and were alternatively treated with or without adjuvant chemotherapy (carboplatin and 5-fluorouracil). Of the 28 patients included in the follow-up (14 with/14 without chemotherapy), 12 patients died (5 with/7 without chemotherapy). The disease-free interval was 18.6 months in the group treated with chemotherapy compared to 29.3 months in the group without chemotherapy. There is no statistically significant difference in the survival of patients with blood vessel invasion in relationship to adjuvant chemotherapy following radical hysterectomy.
- Published
- 1996